Beijing Chunlizhengda Medical Instruments Co., Ltd. (1858.HK)
HKD 8.26
(-1.43%)
HKD 8.26
(-1.43%)
| Breakdown | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 |
|---|---|---|---|---|---|---|
| Revenue | 1.2 Billion | 1.2 Billion | 1.1 Billion | 937.68 Million | 855.32 Million | 497.92 Million |
| Cost of Revenue | 332.63 Million | 288.07 Million | 253.59 Million | 256.93 Million | 261.86 Million | 180 Million |
| Gross Profit | 875.88 Million | 913.52 Million | 854.54 Million | 680.75 Million | 593.45 Million | 317.92 Million |
| Operating Expenses | 549.2 Million | 581.19 Million | 469.3 Million | 345.91 Million | 309.67 Million | 201.14 Million |
| Selling, General and Administrative Expenses | 279.16 Million | 299.83 Million | 352.73 Million | 255.21 Million | 233.17 Million | 150.12 Million |
| Research and Development Expenses | 157.44 Million | 162.34 Million | 104.84 Million | 72.6 Million | 57.74 Million | 35.45 Million |
| Other Expenses | -40.26 Million | 119.01 Million | 11.72 Million | 18.1 Million | 18.75 Million | -150.4 Thousand |
| Cost and Expenses | 902.54 Million | 869.26 Million | 722.9 Million | 602.85 Million | 571.54 Million | 381.14 Million |
| Operating Income | 305.97 Million | 328.9 Million | 367.59 Million | 330.09 Million | 298.57 Million | 121.18 Million |
| Interest Expense | 364.86 Thousand | 16.2 Million | 256.55 Thousand | 141.6 Thousand | 4.89 Million | 1.73 Million |
| Income Tax Expense | 28.08 Million | 29.16 Million | 45.01 Million | 46.47 Million | 36.23 Million | 13.8 Million |
| Earnings before Tax | 305.9 Million | 336.87 Million | 367.37 Million | 329.84 Million | 273 Million | 119.44 Million |
| Net Income | 277.82 Million | 307.71 Million | 322.36 Million | 283.37 Million | 236.76 Million | 105.64 Million |
| Earnings Per Share Basic | 0.72 | 0.80 | 0.93 | 0.82 | 0.68 | 0.31 |
| Earnings Per Share Diluted | 0.72 | 0.80 | 0.93 | 0.82 | 0.68 | 0.31 |
| Weighted Average Shares Outstanding | 385.86 Million | 383.56 Million | 346.62 Million | 345.57 Million | 345.85 Million | 345.85 Million |
| Weighted Average Shares Outstanding (Diluted) | 385.86 Million | 384.64 Million | 346.62 Million | 345.57 Million | 348.17 Million | 345.85 Million |
| Gross Margin | 0.72 | 0.76 | 0.77 | 0.73 | 0.69 | 0.64 |
| EBIT Margin | 0.28 | 0.32 | 0.39 | 0.38 | 0.36 | 0.26 |
| Profit Margin | 0.23 | 0.26 | 0.29 | 0.30 | 0.28 | 0.21 |
| EBITDA | 340.64 Million | 366.96 Million | 360.99 Million | 349.78 Million | 295.57 Million | 124.19 Million |
| Earnings Before Tax Margin | 0.25 | 0.27 | 0.33 | 0.35 | 0.35 | 0.24 |
| Breakdown | 2024 Q2 | 2024 Q1 | 2023 Q4 | 2023 FY | 2023 Q3 | 2023 Q2 |
|---|---|---|---|---|---|---|
| Revenue | 158.28 Million | 221.85 Million | 416.36 Million | 1.2 Billion | 251.44 Million | 294.35 Million |
| Cost of Revenue | 55.43 Million | 58.04 Million | 117.79 Million | 332.63 Million | 83.07 Million | 74.56 Million |
| Gross Profit | 102.84 Million | 163.8 Million | 298.57 Million | 875.88 Million | 168.37 Million | 219.79 Million |
| Operating Expenses | 79.88 Million | 108.19 Million | 196.75 Million | 582.89 Million | 117.8 Million | 153.46 Million |
| Selling, General and Administrative Expenses | 62.48 Million | 76.12 Million | 161.06 Million | - | 117.63 Million | 114.79 Million |
| Research and Development Expenses | 32.66 Million | 34.99 Million | 42.7 Million | - | 40.17 Million | 41.3 Million |
| Other Expenses | -15.27 Million | -6.62 Million | - | -269.6 Thousand | 159.1 Thousand | - |
| Cost and Expenses | 135.31 Million | 166.23 Million | 314.54 Million | 915.53 Million | 200.87 Million | 228.02 Million |
| Operating Income | 22.96 Million | 53.6 Million | 89.7 Million | 305.97 Million | 57.47 Million | 61.2 Million |
| Interest Expense | - | - | - | 85.89 Thousand | 8803.09 | - |
| Income Tax Expense | 948.43 Thousand | 5.05 Million | 12.68 Million | 28.08 Million | 2.85 Million | 6.18 Million |
| Earnings before Tax | 22.9 Million | 60.16 Million | 110.02 Million | 305.9 Million | 57.34 Million | 76.31 Million |
| Net Income | 23.91 Million | 55.1 Million | 97.2 Million | 277.82 Million | 54.63 Million | 70.21 Million |
| Earnings Per Share Basic | 0.07 | 0.14 | 0.25 | - | 0.14 | 0.18 |
| Earnings Per Share Diluted | 0.07 | 0.14 | 0.25 | - | 0.14 | 0.18 |
| Weighted Average Shares Outstanding | 359 Million | 394.28 Million | 390.55 Million | 385.86 Million | 383.56 Million | 391.69 Million |
| Weighted Average Shares Outstanding (Diluted) | 359 Million | 394.28 Million | 390.55 Million | 385.86 Million | 388.8 Million | 391.69 Million |
| Gross Margin | 0.65 | 0.74 | 0.72 | 0.72 | 0.67 | 0.75 |
| EBIT Margin | 0.09 | 0.28 | 0.24 | - | 0.22 | 0.23 |
| Profit Margin | 0.15 | 0.25 | 0.23 | 0.23 | 0.22 | 0.24 |
| EBITDA | 13.97 Million | 61.76 Million | 97.86 Million | - | 54.26 Million | 68.85 Million |
| Earnings Before Tax Margin | 0.15 | 0.24 | 0.22 | 0.25 | 0.23 | 0.21 |
HYT
605117
9919
ALAR
ZOTA
NVVE